Mottiwala Aziz
SEC CIK 1788542 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| TARS | Tarsus Pharmaceuticals, Inc. | Chief Commercial Off | 61.5K | — | $2.87M | 21 | 2021-09-10 | 2026-03-17 |
Most active insiders at TARS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Azamian Bobak R. | Pres, CEO, Board COB, Dir | — | $5.51M |
| 2 | LINK WILLIAM J PHD | Dir | — | $4.48M |
| 3 | Whitfield Dianne C. | CHRO | — | $2.69M |
| 4 | Lin Elizabeth Yeu | Chief Medical Off | — | $2.36M |
| 5 | Neervannan Seshadri | COO | — | $2.00M |
| 6 | Farrow Jeffrey S | See Remarks | — | $1.32M |
| 7 | Mottiwala Aziz | Chief Commercial Off | — | $892.5K |
| 8 | Wahl Bryan | GC | — | $850.4K |
| 9 | Goodrich Katherine | Dir | — | $183.4K |
| 10 | Goldberg Andrew D. | Dir | — | — |
Transactions 21
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-03-19 | 2026-03-17+ | TARS | Tarsus Pharmaceuticals, Inc. | Mottiwala Aziz | Chief Commercial Off | S - Sale | $68.36 | -13.1K | 61.5K | -18% | -$892.5K |
| D | 2026-03-17 | 2026-03-15 | TARS | Tarsus Pharmaceuticals, Inc. | Mottiwala Aziz | Chief Commercial Off | M - OptEx | — | +26.5K | 74.5K | +55% | — |
| 2025-06-11 | 2025-06-09 | TARS | Tarsus Pharmaceuticals, Inc. | Mottiwala Aziz | Chief Commercial Off | S - Sale | $43.76 | -17.5K | 47.6K | -27% | -$765.8K | |
| M | 2025-03-20 | 2025-03-18+ | TARS | Tarsus Pharmaceuticals, Inc. | Mottiwala Aziz | Chief Commercial Off | S - Sale | $47.88 | -10.6K | 68.4K | -13% | -$505.9K |
| D | 2025-03-18 | 2025-03-15 | TARS | Tarsus Pharmaceuticals, Inc. | Mottiwala Aziz | Chief Commercial Off | M - OptEx | — | +21.0K | 75.6K | +38% | — |
| D | 2024-03-19 | 2024-03-18 | TARS | Tarsus Pharmaceuticals, Inc. | Mottiwala Aziz | Chief Commercial Off | S - Sale+OE | $30.60 | -4,766 | 54.1K | -8% | -$145.8K |
| D | 2024-03-19 | 2024-03-15 | TARS | Tarsus Pharmaceuticals, Inc. | Mottiwala Aziz | Chief Commercial Off | M - OptEx | — | +12.9K | 58.8K | +28% | — |
| 2023-07-21 | 2023-07-19 | TARS | Tarsus Pharmaceuticals, Inc. | Mottiwala Aziz | Chief Commercial Off | S - Sale | $20.05 | -2,400 | 45.8K | -5% | -$48.1K | |
| 2023-06-12 | 2023-06-08 | TARS | Tarsus Pharmaceuticals, Inc. | Mottiwala Aziz | Chief Commercial Off | S - Sale | $20.00 | -100 | 48.1K | -0.2% | -$2,000 | |
| M | 2023-06-08 | 2023-06-06+ | TARS | Tarsus Pharmaceuticals, Inc. | Mottiwala Aziz | Chief Commercial Off | S - Sale | $19.00 | -4,643 | 50.7K | -8% | -$88.2K |
| M | 2023-03-23 | 2023-03-21+ | TARS | Tarsus Pharmaceuticals, Inc. | Mottiwala Aziz | Chief Commercial Off | S - Sale | $12.55 | -1,078 | 53.2K | -2% | -$13.5K |
| M | 2023-03-21 | 2023-03-17+ | TARS | Tarsus Pharmaceuticals, Inc. | Mottiwala Aziz | Chief Commercial Off | S - Sale | $12.94 | -697 | 54.3K | -1% | -$9,016 |
| D | 2023-03-17 | 2023-03-16 | TARS | Tarsus Pharmaceuticals, Inc. | Mottiwala Aziz | Chief Commercial Off | S - Sale+OE | $13.43 | -336 | 54.6K | -0.6% | -$4,512 |
| D | 2023-03-17 | 2023-03-15 | TARS | Tarsus Pharmaceuticals, Inc. | Mottiwala Aziz | Chief Commercial Off | M - OptEx | — | +4,790 | 54.9K | +10% | — |
| 2022-11-17 | 2022-11-15 | TARS | Tarsus Pharmaceuticals, Inc. | Mottiwala Aziz | Chief Commercial Off | S - Sale | $17.72 | -6,857 | 49.7K | -12% | -$121.5K | |
| DM | 2022-08-26 | 2022-08-24 | TARS | Tarsus Pharmaceuticals, Inc. | Mottiwala Aziz | Chief Commercial Off | M - OptEx | $9.42 | +5,188 | 55.8K | +10% | +$48.9K |
| 2021-11-10 | 2021-11-08 | TARS | Tarsus Pharmaceuticals, Inc. | Mottiwala Aziz | Chief Commercial Off | S - Sale | $28.11 | -1,889 | 50.2K | -4% | -$53.1K | |
| M | 2021-11-08 | 2021-11-04+ | TARS | Tarsus Pharmaceuticals, Inc. | Mottiwala Aziz | Chief Commercial Off | S - Sale | $28.04 | -111 | 52.1K | -0.2% | -$3,112 |
| M | 2021-11-04 | 2021-11-02 | TARS | Tarsus Pharmaceuticals, Inc. | Mottiwala Aziz | Chief Commercial Off | S - Sale | $26.78 | -6,000 | 52.2K | -10% | -$160.7K |
| DM | 2021-09-14 | 2021-09-10 | TARS | Tarsus Pharmaceuticals, Inc. | Mottiwala Aziz | Chief Commercial Off | M - OptEx | $7.05 | +6,943 | 58.2K | +14% | +$49.0K |
| D | 2021-09-14 | 2021-09-10 | TARS | Tarsus Pharmaceuticals, Inc. | Mottiwala Aziz | Chief Commercial Off | S - Sale+OE | $22.15 | -2,593 | 58.2K | -4% | -$57.4K |
Purchase Sale Sale after option exercise All abbreviations